BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moghimi SM, Simberg D, Skotland T, Yaghmur A, Hunter AC. The Interplay Between Blood Proteins, Complement, and Macrophages on Nanomedicine Performance and Responses. J Pharmacol Exp Ther 2019;370:581-92. [PMID: 30940695 DOI: 10.1124/jpet.119.258012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Moghimi SM, Simberg D. Critical issues and pitfalls in serum and plasma handling for complement analysis in nanomedicine and bionanotechnology. Nano Today 2022;44:101479. [DOI: 10.1016/j.nantod.2022.101479] [Reference Citation Analysis]
2 Fülöp T, Kozma GT, Vashegyi I, Mészáros T, Rosivall L, Urbanics R, Storm G, Metselaar JM, Szebeni J. Liposome-induced hypersensitivity reactions: Risk reduction by design of safe infusion protocols in pigs. Journal of Controlled Release 2019;309:333-8. [DOI: 10.1016/j.jconrel.2019.07.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
3 Cottura N, Howarth A, Rajoli RKR, Siccardi M. The Current Landscape of Novel Formulations and the Role of Mathematical Modeling in Their Development. J Clin Pharmacol 2020;60 Suppl 1:S77-97. [PMID: 33205431 DOI: 10.1002/jcph.1715] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Zaheer Y, Vorup‐jensen T, Webster TJ, Ahmed M, Khan WS, Ihsan A. Protein based nanomedicine: Promising therapeutic modalities against inflammatory disorders. Nano Select 2022;3:733-50. [DOI: 10.1002/nano.202100214] [Reference Citation Analysis]
5 Farshbaf M, Valizadeh H, Panahi Y, Fatahi Y, Chen M, Zarebkohan A, Gao H. The impact of protein corona on the biological behavior of targeting nanomedicines. Int J Pharm 2022;614:121458. [PMID: 35017025 DOI: 10.1016/j.ijpharm.2022.121458] [Reference Citation Analysis]
6 Onyeje C, Lavik E. Highlighting the usage of polymeric nanoparticles for the treatment of traumatic brain injury: A review study. Neurochem Int 2021;147:105048. [PMID: 33901586 DOI: 10.1016/j.neuint.2021.105048] [Reference Citation Analysis]
7 La-Beck NM, Islam MR, Markiewski MM. Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine. Front Immunol 2020;11:603039. [PMID: 33488603 DOI: 10.3389/fimmu.2020.603039] [Reference Citation Analysis]
8 Fan Z, Zhu P, Zhu Y, Wu K, Li CY, Cheng H. Engineering long-circulating nanomaterial delivery systems. Curr Opin Biotechnol 2020;66:131-9. [PMID: 32795661 DOI: 10.1016/j.copbio.2020.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Papini E, Tavano R, Mancin F. Opsonins and Dysopsonins of Nanoparticles: Facts, Concepts, and Methodological Guidelines. Front Immunol 2020;11:567365. [PMID: 33154748 DOI: 10.3389/fimmu.2020.567365] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
10 Chisholm CF, Behnke W, Pokhilchuk Y, Frazer-Abel AA, Randolph TW. Subvisible Particles in IVIg Formulations Activate Complement in Human Serum. J Pharm Sci 2020;109:558-65. [PMID: 31672401 DOI: 10.1016/j.xphs.2019.10.041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Kozma GT, Mészáros T, Vashegyi I, Fülöp T, Örfi E, Dézsi L, Rosivall L, Bavli Y, Urbanics R, Mollnes TE, Barenholz Y, Szebeni J. Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions. ACS Nano 2019;13:9315-24. [PMID: 31348638 DOI: 10.1021/acsnano.9b03942] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 11.7] [Reference Citation Analysis]
12 Pandya AD, Iversen TG, Moestue S, Grinde MT, Mørch Ý, Snipstad S, Åslund AKO, Øy GF, Kildal W, Engebråten O, Sandvig K, Skotland T, Mælandsmo GM. Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft. Nanomaterials (Basel) 2021;11:1140. [PMID: 33924869 DOI: 10.3390/nano11051140] [Reference Citation Analysis]
13 Ummarino A, Gambaro FM, Kon E, Torres Andón F. Therapeutic Manipulation of Macrophages Using Nanotechnological Approaches for the Treatment of Osteoarthritis. Nanomaterials (Basel) 2020;10:E1562. [PMID: 32784839 DOI: 10.3390/nano10081562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Chen BM, Cheng TL, Roffler SR. Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies. ACS Nano 2021;15:14022-48. [PMID: 34469112 DOI: 10.1021/acsnano.1c05922] [Reference Citation Analysis]
15 Yu Helvig S, Woythe L, Pham S, Bor G, Andersen H, Moein Moghimi S, Yaghmur A. A structurally diverse library of glycerol monooleate/oleic acid non-lamellar liquid crystalline nanodispersions stabilized with nonionic methoxypoly(ethylene glycol) (mPEG)-lipids showing variable complement activation properties. J Colloid Interface Sci 2021;582:906-17. [PMID: 32919118 DOI: 10.1016/j.jcis.2020.08.085] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
16 Simberg D, Moghimi SM. Complement Activation by Nanomaterials. In: Bonner JC, Brown JM, editors. Interaction of Nanomaterials with the Immune System. Cham: Springer International Publishing; 2020. pp. 83-98. [DOI: 10.1007/978-3-030-33962-3_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Kad A, Pundir A, Arya SK, Bhardwaj N, Khatri M. An Elucidative Review to Analytically Sieve the Viability of Nanomedicine Market. J Pharm Innov 2020;:1-17. [PMID: 32983280 DOI: 10.1007/s12247-020-09495-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yaghmur A, Tran BV, Moghimi SM. Non-Lamellar Liquid Crystalline Nanocarriers for Thymoquinone Encapsulation. Molecules 2019;25:E16. [PMID: 31861549 DOI: 10.3390/molecules25010016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
19 Zocchi MR, Tosetti F, Benelli R, Poggi A. Cancer Nanomedicine Special Issue Review Anticancer Drug Delivery with Nanoparticles: Extracellular Vesicles or Synthetic Nanobeads as Therapeutic Tools for Conventional Treatment or Immunotherapy. Cancers (Basel) 2020;12:E1886. [PMID: 32668783 DOI: 10.3390/cancers12071886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
20 Xiao Q, Zoulikha M, Qiu M, Teng C, Lin C, Li X, Sallam MA, Xu Q, He W. The effects of protein corona on in vivo fate of nanocarriers. Adv Drug Deliv Rev 2022;:114356. [PMID: 35595022 DOI: 10.1016/j.addr.2022.114356] [Reference Citation Analysis]
21 Bedőcs P, Szebeni J. The Critical Choice of Animal Models in Nanomedicine Safety Assessment: A Lesson Learned From Hemoglobin-Based Oxygen Carriers. Front Immunol 2020;11:584966. [PMID: 33193403 DOI: 10.3389/fimmu.2020.584966] [Reference Citation Analysis]
22 Eleamen Oliveira E, Barendji M, Vauthier C. Understanding Nanomedicine Size and Biological Response Dependency: What Is the Relevance of Previous Relationships Established on Only Batch-Mode DLS-Measured Sizes? Pharm Res 2020;37. [DOI: 10.1007/s11095-020-02869-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
23 Moghimi SM, Simberg D, Papini E, Farhangrazi ZS. Complement activation by drug carriers and particulate pharmaceuticals: Principles, challenges and opportunities. Adv Drug Deliv Rev 2020;157:83-95. [PMID: 32389761 DOI: 10.1016/j.addr.2020.04.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
24 Brain D, Plant-Hately A, Heaton B, Arshad U, David C, Hedrich C, Owen A, Liptrott NJ. Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19. Adv Drug Deliv Rev 2021;:113848. [PMID: 34182016 DOI: 10.1016/j.addr.2021.113848] [Reference Citation Analysis]
25 Brenner JS, Mitragotri S, Muzykantov VR. Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers. Annu Rev Biomed Eng 2021;23:225-48. [PMID: 33788581 DOI: 10.1146/annurev-bioeng-121219-024239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Onishchenko N, Tretiakova D, Vodovozova E. Spotlight on the protein corona of liposomes. Acta Biomater 2021:S1742-7061(21)00512-2. [PMID: 34364016 DOI: 10.1016/j.actbio.2021.07.074] [Reference Citation Analysis]
27 Boraschi D, Alijagic A, Auguste M, Barbero F, Ferrari E, Hernadi S, Mayall C, Michelini S, Navarro Pacheco NI, Prinelli A, Swart E, Swartzwelter BJ, Bastús NG, Canesi L, Drobne D, Duschl A, Ewart MA, Horejs-Hoeck J, Italiani P, Kemmerling B, Kille P, Prochazkova P, Puntes VF, Spurgeon DJ, Svendsen C, Wilde CJ, Pinsino A. Addressing Nanomaterial Immunosafety by Evaluating Innate Immunity across Living Species. Small 2020;16:e2000598. [PMID: 32363795 DOI: 10.1002/smll.202000598] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
28 Di J, Gao X, Du Y, Zhang H, Gao J, Zheng A. Size, shape, charge and “stealthy” surface: Carrier properties affect the drug circulation time in vivo. Asian Journal of Pharmaceutical Sciences 2020. [DOI: 10.1016/j.ajps.2020.07.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
29 Giulimondi F, Vulpis E, Digiacomo L, Giuli MV, Mancusi A, Capriotti AL, Laganà A, Cerrato A, Zenezini Chiozzi R, Nicoletti C, Amenitsch H, Cardarelli F, Masuelli L, Bei R, Screpanti I, Pozzi D, Zingoni A, Checquolo S, Caracciolo G. Opsonin-Deficient Nucleoproteic Corona Endows UnPEGylated Liposomes with Stealth Properties In Vivo. ACS Nano 2022. [PMID: 35040637 DOI: 10.1021/acsnano.1c07687] [Reference Citation Analysis]
30 Szebeni J, Bawa R. Human Clinical Relevance of the Porcine Model of Pseudoallergic Infusion Reactions. Biomedicines 2020;8:E82. [PMID: 32276476 DOI: 10.3390/biomedicines8040082] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
31 Della Camera G, Lipsa D, Mehn D, Italiani P, Boraschi D, Gioria S. A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses. Int J Mol Sci 2021;22:E820. [PMID: 33467541 DOI: 10.3390/ijms22020820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]